Foundation News

Stay up-to-date with the most current news and information about the Crohn's & Colitis Foundation, as well as Crohn's disease and ulcerative colitis.

Filter results

Landmark Study Reveals Over 100,000 American Youth Living with Inflammatory Bowel Disease

November 20, 2024

Announcing our Northwest Chapter Auxiliary Board

10/11/2024 — The Northwest Chapter is thrilled to welcome Aleah Deschmidt, Lexie McGinty, and Nina Stashto the Northwest Chapter Auxiliary Board.

October 11, 2024

Crohn's & Colitis Foundation Survey Reveals More Than 40% of IBD Patients Made Significant Financial Sacrifices to Pay for Their Healthcare

Embargoed until 9:00 a.m. ET October 8, 2024

October 1, 2024

The Crohn's & Colitis Foundation Appoints Chris Fidyk as Executive Vice President, Business Development

Contact: Rachel Peifer [email protected]

September 24, 2024

In the News Spotlight: Boca Chamber

To read the latest press release featuring the Crohn's & Colitis Foundation from the Boca Chamber of Commerce click here!

August 20, 2024

Crohn's & Colitis Foundation Announces New Five-Year Research Agenda

June 4, 2024

CytoReason and the Crohn’s & Colitis Foundation Forge Groundbreaking Data Collaboration to Advance IBD Research

May 16, 2024

Crohn’s & Colitis Foundation and Evotec Enter Agreement to Advance Drug Discovery for Novel IBD Therapies

he Crohn’s & Colitis Foundation has joined forces with life science company Evotec SE, to help advance drug discovery for two innovative drug targets stemming from cutting-edge academic research for inflammatory bowel disease (IBD), which includes Crohn's disease and ulcerative colitis.

January 9, 2024

Dec 1-7 Proclaimed Crohn's & Colitis Awareness Week

Seattle, 11/30/2023 — The Northwest Chapter of the Crohn's and Colitis Foundation is proud to recognizeCrohn’s & Colitis Awareness Week from December 1 to 7.

December 8, 2023

The Crohn’s & Colitis Foundation Joins Forces with the Mark Cuban Cost Plus Drug Company to Improve Medication Access for IBD Patients

The Crohn’s & Colitis Foundation, the nation’s leading nonprofit organization focused on research and patient support for inflammatory bowel disease (IBD), is joining forces with the Mark Cuban Cost Plus Drug Company (Cost Plus Drugs) to increase awareness of opportunities for accessing some reduced-price essential IBD medications.

October 3, 2023